Skip to content

Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis

The Value of Subjective Near-infrared Fluorescence Guidance in Assessment of Perfusion During Restorative Ileal Pouch Formation and Ileal-pouch-anal Anastomosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04695184
Enrollment
50
Registered
2021-01-05
Start date
2019-02-01
Completion date
2021-01-31
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Crohn Colitis, Crohn Disease, Familial Adenomatous Polyposis, Ileal Pouch, Ulcerative Colitis

Keywords

indocyanine green, restorative proctocolectomy, ileal pouch-anal anastomosis, subjective perfusion rate, near-infrared fluorescence, ulcerative colitis, anastomotic leak, pouchitis

Brief summary

In this prospective, non-randomized cohort study, real-time intraoperative visualization using near-infrared-fluorescence by indocyanine green injection (ICG-NIRF) is performed at three time points during ileal pouch reconstruction. The intraoperative imaging findings are then analysed and correlated with the 30 day postoperative clinical outcome including occurrence of anastomotic leak of the pouch.

Detailed description

Near-infrared-fluorescence by indocyanine green (ICG-NIRF) utilises the fluorescent property of intravenously injected indocyanine green (ICG) as an intravascular indicator of tissue and bowel perfusion. The investigators hypothesise that ICG-NIRF is a suitable, reliable and precise method of visualisation of the blood supply and bowel perfusion in the area of ileal pouch formation and the ileal pouch-anal anastomosis. In this prospective, non-randomized cohort study, restorative proctocolectomy with ileal pouch reconstruction and ileal pouch-anal anastomosis is performed according to standard of care for medically-refractory ulcerative colitis (UC), UC-associated neoplasia, medically-refractory Crohn´s colitis, colorectal carcinoma or familial adenomatous polyposis (FAP) in open or laparoscopic surgery, according to the surgeon's choice. Written informed consent for participation and ICG-administration is obtained one day before surgery. Intraoperatively, Indocyanine Green (VerDye, Diagnostic Green GmbH, Aschheim Germany, 25 mg vials) is dissolved in 5 mL sterile water to yield a 5 mg/mL concentration. It will then be administered intravenously at three consecutive time points as a bolus of 2 ml per time point at the most. The overall dose of ICG will amount to no more than 30mg of ICG per patient. Real-time intraoperative visualization is performed with the SpectrumTM Fluorescence Imaging Platform (Quest Innovations, Middenmeer, The Netherlands) directly after each ICG injection assessing bowel perfusion at three different time points respectively: before and after J-Pouch construction by stapler anastomosis and after ileoanal anastomosis formation. Clinical data and follow-up Clinical data is be collected from all patients regarding anastomotic leak, bowel ischemia and necrosis as well as 30 day postoperative morbidity, mortality and length and cost of hospital stay. Subjective data analysis will performed using Microsoft Excel® and IBM SPSS®.

Interventions

DIAGNOSTIC_TESTICG-NIRF Imaging

intraoperative NIRF Imaging using the fluorescence agent ICG (indocyanine-green) at regions of interest before (T1) + after pouch construction (T2) + after ileoanal anastomosis (T3)

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

This is a non randomised prospective cohort study design.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥ 18 * capability of signing the informed consent * diagnosis of therapy resistent ulcerative colitis, colorectal cancer, Crohn's disease, familial adenomatous polyposis * restaurative proctocolectomy (RPC) with reconstruction through ileal pouch formation and ileal pouch-anal anastomosis (IPAA) is possible and medically indicated * ASA score ≤ 3

Exclusion criteria

* coexistent malignant tumor of a different ethology * liver disfunction (MELD score \> 10) * ICG (indocyanine green) specific

Design outcomes

Primary

MeasureTime frameDescription
anastomotic leak30 daysoccurrence of anastomotic leak within 30 days of surgery

Secondary

MeasureTime frameDescription
Operative and post-operative complications30 daysClavien-Dindo for complication-level classification
Length of post-operative hospital stay100 dayslength in days

Countries

Germany

Contacts

Primary ContactBenjamin Weixler, MD PD
benjamin.weixler@charite.de+49 30 450 622 798
Backup ContactLeonard Lobbes, MD
leonard.lobbes@charite.de+49 30 450 622 789

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026